Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating varenicline with nicotine lozenges and a smartphone adherence intervention for smoking cessation, currently not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine lozenges (nicotine lozenge)
  • Varenicline (varenicline)

Snippet

Sponsor: University of Oklahoma | Conditions: Smoking Cessation | Phase 2 | Status: NOT_YET_RECRUITING